Both dupilumab and mepolizumab were originally approved for asthma but were subsequently studied in patients with COPD who continue to experience symptoms and moderate-to-severe exacerbations despite ...

Please provide your email address to receive an email when new articles are posted on . The new diagnoses rates for COPD and asthma in the first year of the COVID-19 pandemic were lower than the ...

Patients with mild asthma exposed to higher levels of O3 and NO2, but not PM2.5, were associated with an increased risk for asthma exacerbation.

While serious complications from asthma have been on the downswing, the rise of obesity could blunt that progress. Here’s how to help your patients with obesity and asthma.

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...

More than 75% of adults in a virtual asthma self-management education program had improved asthma control afterward, according to data presented at the American Academy of Allergy, Asthma & Immunology ...

Elastic parametric response mapping (ePRM), a CT-based severity scoring system for regional lung volumes, can monitor COPD progression.

In a synopsis of a clinical practice guideline issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and published online Feb. 17 in the Annals of Internal Medicine, updated ...

Findings based on comparison to glycopyrrolate-formoterol and tiotropium-olodaterol in patients newly prescribed LAMA-LABA inhalers.

Asthma exacerbation risk appeared to be reduced in patients receiving treatment with certain immune checkpoint inhibitors (ICIs), according to study results presented at the American Academy of ...